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Introduction. Bronchial asthma is one of the most common chronic diseases among children 
and adults over 40 years . This illness requires complex treatment, aimed at avoiding trigger 
factors, medication, physical and psychological therapy. The prevalence of this pathology in the 
country is 4%, with 160 thousand asthmatics registered. The disease predominates in male 
gender, with a ratio of 1.5-3 / 1. The overall prevalence of asthma varies from 1% to 18% in 
different countries and the mortality rate is currently estimated between 2 and 4 cases per 
100,000 population in a year.  
Aim of the study. Assessment of bronchial asthma medication of the 4 stages of severity 
(intermittent, persistent, moderately persistent and severely persistent) in terms of the 5 stages of 
treatment.  
Materials and methods. Analysis of data from the speciality literature of the last 5 years.  
Results. Depending on the level of control and the evolution of the disease, the treatment of 
asthma is accomplished in 5 steps. For all stages, emergency medication consists of β2 rapid-
acting inhaled agonists (salbutamol nictimer dose 600-800 μg, fenoterol 600 μg) inhaled 
anticholinergic drugs (ipantropium bromide 60-120 μg) and methylxanthines (300-800 μg 
theophylline). At Stage 1, treatment is indicated for patients who experience symptoms of AB 
less than 2 times a week. For this patient group only emergency medication is used. Step 2 is 
addressed to patients with persistent asthma symptoms. In the control medication, low-dose 
inhaled corticosteroids or leukotriene antagonists (montelucast 10 mg, zafirlucast 20 mg) are 
recommended. Step 3 is for patients who lack control under treatment 1 and 2. For maintenance, 
combinations of β2-agonists + CSI, leukotriene + CSI antagonists or theophylline retard + CSI 
are recommended. Step 4 is recommended for patients who are unstable in 3rd stage treatment. 
Control medication includes: Long-acting CSI + β2 agonists + small doses of retard 
theophylline. Step 5 treatment is for those with severe AB. The medication is orally CS + anti-IG 
E.  
Conclusions. The division of the contemporary AB treatment in the 5 stages would lead to the 
exclusion of overdosing and would allow a more individualized and personalized approach for 
the patient. 
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Introduction. The anxiety disorders, depression and stress disorders are brought on by 
psychological challenges faced by a large number of people. Based on the WHO data, the 
number of people that suffer from depression has increased to 322 million, or more than 18 
percent over the last decade. The therapy of mental disorders needs a continuous updating. At the 
lab of organic and biopharmaceutical synthesis in the University of chemistry, a new, 
autochthonous compound was synthesized in the isatine group, with the pronounced anti-
depressive, sedative and tranquilizing activity (according to preliminary studies). 
Aim of the study. To investigate the spectral characteristics of the substance 1’-(2-oxo-propil)-
spiro[[1,3]dioxolane-2’,3’-indolin]-2’-one. 
Materials and methods. We used Spectrophotometers UV-VIS Agilent 8453 and Bruker AC-E 
400 SUA, a device used to determine the melting point Melting-Point Meter KSPII, electronic 
balance OHAUS DV125 CD, chemical dishes, solvents and regents, according to the 
requirements of the European Pharmacopoeia.  
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Results. The substance, formula bruto C13H13NO4, Mr =247,25, represents an odorless white 
crystalline powder, slightly soluble in alcohol, chloroform and benzene, poorly soluble in water 
and ether. Melting point 125-127ºC. The spectrum in alcohol was recorded in the range of 
wavelength 200-360 nm. The alcoholic solution 2,5mg/L manifests 2 maxims with a different 
intensity: at 215 ± 2 nm ( 3150 and at 258 ± 2 nm ( 490). Some spectrum of nuclear magnetic 
resonance 1H and 13C RMN (200.13 and 50.32 MHz) in 2-% solution of CDCl3 were recorded. 
The value of chemical movements is in the system δ ppm to the signal TMS in correlation with 
the signals CHCl3 (δH 7.24 şi δC 77.0 ppm). 1Н NMR δ, ppm, J/Hz: 2.17 s (3H, Me), 4.28-4.39 
m (4H, 2CH2), 4.51-4.60 m (2H, CH2), 7.07-7.11 t (1H, CH, J=7.36 Hz), 7.29-7.33 t (1H, CH, 
J=7.65 Hz), 7.38-7.39 d (1H, CH, J=7.36 Hz). 13С NMR, δ, ppm: 201.85 (C=O), 173.25 
(NC=O), 143.35 (C4), 131.86 (C7a), 125.14 (C3), 123.70 (C5), 108.52 (C6), 102.13 (C7), 
101.97(C3a), 65.69 (OCH2), 27.02 (Me). 
Conclusions. The results of the study of spectral characteristics of 1’-(2-oxo-propil)-spiro [[1,3] 
dioxolane-2’, 3’-indolin]-2’-one will be used to elaborate the methods of analysis and 
standardization for this substance.  
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Introduction. Burns in children are serious tissue damage with necrosis of skin, adipose tissue, 
muscles, tendons, nerves, blood vessels, bones, disturbances of homeostasis, with the 
development of acute multiorganic failure syndrome and septic complications. These 
circumstances require the development of measures for the prophylaxis and treatment of 
pathological disorders developed locally and in the organs’ system due to thermal trauma. 
Depending on the depth degree, we distinguish burns of I, II, III, IV degrees. The distribution of 
burns according to heat transfer mechanism and aggression type is: 72.8% - hot liquids; 14.2% - 
flame; 8.7% - incandescent objects; 3.6% - electrical; 0.7% - chemical, solar. According to the 
statistics of the Republican Clinic of Burns and Plastic Surgery, burns make up 5-6% of all acute 
pediatric traumas. Breakdown of burns by age: 0-3 years 48.6%; 3-7 years 22.4%; 7-15 years 
29.0%. According to world statistics, burns constitute a very important issue due to their high 
frequency in the pediatric population of about 3.4-36%.  
Aim of the study. To elucidate the particularities of the development of burns in children and 
some correct contemporary principles in the administration and monitoring of specific treatment.  
Materials and methods. Analysis of data from the Clinic of Burns and Plastic Surgery during 
2007-2017.  
Results. In the last 10 years, 5715 children with burns (0-3 years - 50.6%, 4-7 years - 24.4%, 8-
18 years - 25%) were treated in the Clinic of Burns and {Plastic} Surgery. Of which: 2844 
(55.2%) – with superficial burns, 2871 (44.8%) – with deep burns and 645 children were 
hospitalized with combustion shock. Contemporary treatment of burns and post-combustion 
sequelae consists of: necrophasciotomies, amputations, joint amputations, early necrectomies, 
free skin plastics, plastics with pedicle flaps, plastics with remotely migrated flaps, tissue 
expansion, but also of drug application. Currently, early surgical treatment of deep burns has 
become an axiom because the combustion disease consequences depend directly on the skin 
restoration term.  
